How to Inject Tirzepatide: Step-by-Step Guide

Q: What needle size is used for tirzepatide injections?

Tirzepatide is typically injected using a short, thin needle, often 4mm to 8mm in length and 29 to 32 gauge. Shorter needles such as 4-5mm are commonly preferred for subcutaneous injections because they reduce discomfort.

Q: Where on the body do you inject tirzepatide?

Common injection sites include the abdomen (at least 2 inches from the navel), the outer thigh, and the back of the upper arm. Rotating between sites each week helps reduce tissue irritation and the buildup of lumps under the skin.

Q: Does tirzepatide need to be refrigerated?

Yes, tirzepatide should be stored in the refrigerator at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). After first use it can be kept at room temperature up to 77 degrees Fahrenheit (25 degrees Celsius) for up to 21 days. Never freeze it.

Q: How often is tirzepatide injected?

Tirzepatide is designed as a once-weekly subcutaneous injection. Most research protocols and clinical uses follow the same weekly schedule, with the injection done on the same day each week to maintain consistent levels.

Built by medical professionals, gym rats, and experienced biohackers

Quick Answer

Tirzepatide is administered as a subcutaneous (under-the-skin) injection, typically once per week . The injection goes into fatty tissue at sites like the abdomen, outer thigh, or upper arm. Proper technique, site rotation, and storage make a meaningful difference in comfort and consistency over time.

What Tirzepatide Is and Why It Is Injected

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormone receptors involved in blood sugar regulation and appetite signaling . Unlike single-target GLP-1 compounds, tirzepatide's dual mechanism has drawn significant research interest for its effects on metabolic function .

Because it is a peptide-based compound, tirzepatide cannot survive oral ingestion. The digestive system breaks it down before it can reach the bloodstream. Subcutaneous injection delivers it into fatty tissue, where it absorbs gradually and consistently into circulation.

Understanding the injection process helps ensure accurate, repeatable dosing and protects tissue health over weeks and months of use.

Supplies You Will Need

Before each injection, gather the following:

Tirzepatide (drawn into an insulin syringe or from a pre-filled auto-injector pen)
A fresh needle, typically 29 to 32 gauge and 4 to 8mm in length
Alcohol swabs
A sharps disposal container
A clean, well-lit workspace

Never reuse needles. A used needle develops microscopic barbs that increase pain and the chance of local irritation. Always use a new needle for each injection.

Choosing Your Injection Site

Tirzepatide goes into the subcutaneous layer, the fatty tissue just below the skin. The three most common sites are:

Abdomen: Inject at least 2 inches from the navel. This site is easy to reach and has consistent fatty tissue in most people. Avoid the area directly around the navel.

Outer thigh: Use the middle outer portion of the thigh. Avoid the inner thigh and the area directly above the knee, where tissue is thinner and nerves are closer to the surface.

Back of the upper arm: This site is harder to self-administer and may need assistance, but it is a solid rotation option for those avoiding the abdomen or thigh.

Rotation matters. Injecting the same small area repeatedly causes lipodystrophy, a condition where fat tissue breaks down or hardens at the injection site . Most protocols recommend moving to a different site each week and varying the exact spot within a site to allow tissue recovery.

Step-by-Step Injection Technique

Wash your hands thoroughly with soap and water for at least 20 seconds.
Inspect the solution. Tirzepatide should appear clear to slightly yellow and be free of particles. Do not use it if it looks cloudy or contains floating material.
Clean the injection site with an alcohol swab. Let the area dry fully before injecting. Injecting into wet skin can cause stinging and slightly increases contamination risk.
Pinch the skin gently between your thumb and index finger to lift the fatty layer away from the underlying muscle.
Insert the needle at a 45-degree angle for people with less subcutaneous fat, or at 90 degrees for those with more. The goal is to land in fat, not muscle tissue.
Inject slowly. Push the plunger at a steady, even pace. Rushing can cause the solution to pool under the skin or create localized pressure that increases discomfort.
Remove the needle at the same angle it went in. Apply gentle pressure with a clean cotton ball or gauze if there is minor bleeding. Do not rub the site, as rubbing can disperse the compound unevenly.
Dispose of the needle immediately in a sharps container. Never recap a used needle using both hands.

People who track multi-week peptide protocols often use a dedicated logging tool to record injection sites, dates, and dose amounts. DoseVault is built specifically for this, with injection site rotation tracking and dose history in one place.

Dosing and Titration

Research and clinical use typically starts at a lower dose to assess individual tolerance before moving upward . Common starting points in published research begin at 2.5 mg per week, with incremental increases at roughly 4-week intervals . Doses in clinical protocols have been studied up to 15 mg per week .

Specific dose, schedule, and titration approach depend entirely on the research context or clinical protocol being followed. No dose decision should be made without professional oversight. This page does not recommend any specific dose or schedule.

Storage and Handling

Correct storage protects potency. Key points:

Store unused tirzepatide in the refrigerator between 36 and 46 degrees Fahrenheit (2 to 8 degrees Celsius)
After first use, the product can be stored at room temperature up to 77 degrees Fahrenheit (25 degrees Celsius) for up to 21 days
Never freeze tirzepatide, as freezing degrades peptide bonds
Keep it away from direct sunlight and heat sources
Do not use tirzepatide past its expiration date

If reconstituting from lyophilized (freeze-dried) powder, bacteriostatic water is the standard reconstitution solvent . Draw the water along the inside wall of the vial and swirl gently to mix. Do not shake the vial, as shaking can denature the peptide and reduce potency.

Common Mistakes to Avoid

Injecting cold solution. Let refrigerated tirzepatide sit at room temperature for 15 to 30 minutes before injecting. Cold solution is thicker and more likely to cause discomfort at the site.
Inconsistent timing. Weekly injections work best when done on the same day each week to maintain stable systemic exposure .
Skipping site rotation. Repeated injections in the same spot cause cumulative tissue damage over weeks.
Not letting the swab dry. A wet injection site can sting and slightly increases surface contamination risk.
Using degraded product. Potency drops when tirzepatide is stored outside recommended conditions or past its expiration.

Frequently Asked Questions

What needle size is used for tirzepatide injections?
Short, thin needles are standard. Most people use 29 to 32 gauge needles that are 4 to 8mm long . Shorter needles in the 4 to 5mm range are often preferred for comfort and work well for most subcutaneous sites.

Where on the body do you inject tirzepatide?
The abdomen (at least 2 inches from the navel), the outer thigh, and the back of the upper arm are the three main sites. Rotating between them weekly is important for long-term tissue health.

Does tirzepatide need to be refrigerated?
Yes. Unused tirzepatide should be refrigerated at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). After first use, it can be kept at room temperature up to 77 degrees Fahrenheit (25 degrees Celsius) for up to 21 days . Freezing damages the compound.

How often is tirzepatide injected?
Tirzepatide follows a once-weekly subcutaneous injection schedule in both research and clinical settings . Most protocols call for injecting on the same day each week to maintain consistent exposure between doses.

Disclaimer: This content is for educational purposes only. It is not medical advice. Tirzepatide is not FDA-approved for general use outside of specific approved indications, and research-grade compounds carry additional variables and risks. Always consult a licensed healthcare provider before starting any injection protocol.

Built by medical professionals, gym rats, and experienced biohackers

Tracking your peptide protocols accurately makes a real difference in spotting what is and is not working. DoseVault is a free tool built for researchers and self-experimenters who want clean dose logs, injection site rotation reminders, and full protocol history in one place. Start logging your protocol at DoseVault today.